Delivery Order SPE2DR25D3301-SPE2DR26F19EB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Varivax vaccine with diluents. This competitively awarded, non-set-aside contract carries a ceiling value of $14,991.90 and is structured as a firm fixed-price delivery order with a completion date of December 24, 2025. The vaccines will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,020.70 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on December 10, 2025, with an ultimate completion date of January 2, 2026, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete in the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,039.38 on November 28, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by December 19, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Varivax vaccine with diluents, valued at $6,532.31. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work is scheduled for completion by December 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Varivax vaccine with diluents, valued at $7,297.92. This firm fixed-price delivery order is scheduled for completion by September 18, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the contractor's established capability to meet federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,047.90 to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of December 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 10, 2025, with a ceiling value of $5,160.55 and ultimate completion date of October 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Varivax vaccine with diluents, valued at $1,019.65 with a completion date of December 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, valued at $9,994.60, is scheduled for completion by December 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19EBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Varivax vaccine with diluents. This $19,839 firm fixed price delivery order is scheduled for completion by December 31, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through the company's existing contract vehicle. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceuticals, vaccines, and medical supplies to support military and veteran healthcare systems. The DLA Troop Support Medical contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to fulfill diverse medical commodity requirements across multiple therapeutic domains for customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 12/8/25 |